PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17822662-7	2007	Clarithromycin resistance was found to be 44.1% (15/34) in the PAC-1 group and 58.8% (20/34) in the PAC-2 group (p>0.05).	Clarithromycin	0-14	dual specificity phosphatase 2	Homo sapiens	63-68	
17822662-9	2007	H. pylori was eradicated in 4 of 15 (PP: 26.7%, ITT: 26.7%) clarithromycin-resistant patients in the PAC-1 group and in 12 of 20 (PP: 60%, ITT: 60%) clarithromycin-resistant patients in the PAC-2 group (p>0.05).	Clarithromycin	60-74	dual specificity phosphatase 2	Homo sapiens	101-106	
17822662-10	2007	Among the clarithromycin-sensitive ones, eradication was achieved in 12 of 19 (PP: 63.2%, ITT: 57.1%) patients in the PAC-1 group and in 13 of 14 (PP: 92.8%, ITT: 76.5%) patients in the PAC-2 group (p>0.05).	Clarithromycin	10-24	dual specificity phosphatase 2	Homo sapiens	118-123